Results 291 to 300 of about 176,987 (331)

"Electronic Pediatrician", a non-machine learning prototype artificial intelligence software for pediatric computer-assisted pathophysiologic diagnosis - general presentation. [PDF]

World J Methodol
Drăgoi AL, Nemeș RM.
europepmc   +1 more source

Is the incidence of early‐onset cancers increasing in the northeast of Italy? A 30‐year analysis of the regional cancer registration data by age, 1987–2019

International Journal of Cancer, EarlyView.
Whats New? This observational study of the incidence trends of malignancy by site, stratified by age group and sex, over three decades in a large northern Italian population reveals a heterogeneous landscape among younger adults (aged under 50). Invasive cutaneous melanoma in both sexes, testicular cancer and multiple myeloma in males, and breast ...
Alessandra Buja, Chiara Trevisiol, Andrea Miatton, Stefano Guzzinati, Emanuela Bovo, Simone Mocellin, Alberto Fantin, Massimo Rugge, Vincenzo Bronte, Manuel Zorzi   +9 more
wiley   +1 more source

Hysteresis of the lower esophageal sphincter: relevance to the pathogenesis of esophageal achalasia and its phenotypes. [PDF]

Am J Physiol Gastrointest Liver Physiol
Jain AS, Breaux W, Robertson JK, Kim SE, McAdoo B, Keilin S, Fernandez F, Srinivasan S, Mittal RK.   +8 more
europepmc   +1 more source

Body height and the excess cancer risk in men

International Journal of Cancer, EarlyView.
What's New? In cancers that affect both sexes, men usually have a higher risk than women. While this is often attributed to behavioral factors, such as exposure to environmental carcinogens, there may be an intrinsic biological mechanism involved. Tall stature has been associated with increased cancer risk.
Cecilia Radkiewicz, Gustaf Edgren, Arvid Sjölander, Emelie Benyi, Mats Lambe, Paul W. Dickman, Lars Sävendahl   +6 more
wiley   +1 more source

Correlation between sarcopenia diagnosed by C3SMI criteria and prognosis in esophageal cancer patients after radiotherapy. [PDF]

World J Gastrointest Oncol
Wang DE, Qin XF, Yang W.
europepmc   +1 more source

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey

International Journal of Cancer, EarlyView.
What's New? This study quantified the cancer burden attributable to modifiable risk factors in Guangdong, the most populous and economically advanced province in southern China. By evaluating 15 modifiable risk factors, the study reveals that over one‐third of cancer cases and two‐fifths of cancer deaths in the region could potentially be prevented ...
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang   +17 more
wiley   +1 more source

Study design of the phase IV, randomized, placebo-controlled REMOdeling with Dupilumab in Eosinophilic esophagitis Long-term (REMODEL) trial. [PDF]

Therap Adv Gastroenterol
Dellon ES, Savarino EV, Zaghloul S, Angello JT, Zhang M, Raphael BP, Radwan A, Bredenoord AJ.   +7 more
europepmc   +1 more source

Quality of life in cancer patients at the end of radiotherapy compared to a general population sample in Germany

International Journal of Cancer, EarlyView.
What's New? While radiotherapy is an essential component of oncology treatment, it remains unclear how the quality of life of treated patients compares to that of the general population. This pooled secondary analysis of two cross‐sectional studies conducted in Germany reveals existing gaps in global quality of life between the general population and ...
Alexander Fabian, Alexander Rühle, Gregor Liegl, Justus Domschikowski, Maike Trommer, Simone Ferdinandus, Jan‐Niklas Becker, Georg Wurschi, Simon Boeke, Mathias Sonnhoff, Christoph Grott, Lukas Käsmann, Melanie Schneider, Sandra Freitag‐Wolf, Nils H. Nicolay, David Krug, Sandra Nolte   +16 more
wiley   +1 more source

Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real‐world matched comparison of overall survival

International Journal of Cancer, EarlyView.
What's New? Patients with esophageal or gastroesophageal junction (GEJ) cancer with residual disease after treatment with neoadjuvant chemoradiotherapy (nCRT) and resection frequently experience poor survival. Improvements in outcome, however, may be possible using adjuvant treatment with nivolumab.
Rob H. A. Verhoeven, Steven C. Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I. van Berge Henegouwen, Peter S. N. van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W. M. van Laarhoven   +9 more
wiley   +1 more source

Tacrolimus-Induced Acute Esophageal Necrosis Postorthotopic Liver Transplantation. [PDF]

ACG Case Rep J
Tang W, Dawkins M, Basta D, Hara N, Shakil F, Roxana B, Pais S, Okumura K, Nishida S, Dhand A.   +9 more
europepmc   +1 more source